By Karuna Jaggar, Executive Director
Breast Cancer Action’s case against the BRCA gene patent is going to the Supreme Court! Please join me in Washington, DC on Wednesday, January 30th to learn more about our upcoming case against Myriad Genetics, the company that holds a patent on the BRCA1&2 genes (the so-called “breast cancer” genes.) Breast Cancer Action is the only breast cancer organization that is a plaintiff in this landmark case represented by the ACLU.
It’s my pleasure to invite you to join me and Chris Hansen, the lead ACLU attorney on the case, for an informative and interactive conversation to ask questions, and learn about the moral and legal issues at stake for women at risk of and living with breast cancer, and for all of us.
We believe it’s wrong for one company to dictate all scientific and medical uses of basic human genes that each of us has in our bodies. You and I both know how urgently we need more and better options for the treatment and risk reduction of breast cancer, and we will not allow this to be blocked by the monopolies that this gene patents creates.
Please join us on January 30th and bring your friends, family, and colleagues to learn more about this groundbreaking case. Learn more about upcoming actions and events–and find out how you can get involved, and make a difference.
What: Take Back My Genes: An informative and interactive conversation with Karuna Jaggar, Executive Director of Breast Cancer Action, and Chris Hansen, Senior National Staff Counsel at ACLU
When: Wednesday, January 30th, 5:30-7:00pm
Where: Friends of the Earth offices
1100 15th St NW, 11th Floor
Washington, DC 20005
Light refreshments will be provided
The event is free, though donations are accepted. Please RSVP via email to email@example.com. I look forward to seeing you there!